Standout Papers

A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With... 2003 2026 2010 2018 3.3k
  1. A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C (2003)
    Chun‐Tao Wai, Joel K. Greenson et al. Hepatology
  2. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance (2018)
    Norah A. Terrault, Anna S. Lok et al. Hepatology
  3. Chronic hepatitis B: Update 2009 # (2009)
    Anna S. Lok, Brian J. McMahon Hepatology
  4. Chronic hepatitis B (2007)
    Anna S. Lok, Brian J. McMahon Hepatology
  5. Hepatitis B virus infection (2014)
    C. Trépo, Henry Lik‐Yuen Chan et al. The Lancet
  6. A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B (2006)
    Ting‐Tsung Chang, Robert G. Gish et al. New England Journal of Medicine
  7. Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B (2006)
    Ching‐Lung Lai, Daniel Shouval et al. New England Journal of Medicine
  8. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy (1991)
    Anna S. Lok, Raymond Liang et al. Gastroenterology
  9. Management of hepatitis B: 2000—Summary of a workshop (2001)
    Anna S. Lok, E. Jenny Heathcote et al. Gastroenterology
  10. Long-term safety of lamivudine treatment in patients with chronic hepatitis B (2003)
    Anna S. Lok, Ching‐Lung Lai et al. Gastroenterology
  11. α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma (2009)
    Jorge A. Marrero, Ziding Feng et al. Gastroenterology
  12. Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1 (2012)
    Anna S. Lok, David Gardiner et al. New England Journal of Medicine
  13. Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis (2015)
    Anna S. Lok, Brian J. McMahon et al. Hepatology
  14. Use of Liver Imaging and Biopsy in Clinical Practice (2017)
    Elliot B. Tapper, Anna S. Lok New England Journal of Medicine
  15. Hepatitis B (2023)
    Wen‐Juei Jeng, George Papatheodoridis et al. The Lancet
  16. How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development? (2022)
    Grace Lai–Hung Wong, Ed Gane et al. Journal of Hepatology
  17. The scientific basis of combination therapy for chronic hepatitis B functional cure (2023)
    Seng Gee Lim, Thomas F. Baumert et al. Nature Reviews Gastroenterology & Hepatology

Immediate Impact

7 by Nobel laureates 5 from Science/Nature 115 standout
Sub-graph 1 of 16

Citing Papers

New Approaches to Chronic Hepatitis B
2023 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
31 intermediate papers

Works of Anna S. Lok being referenced

Progress towards elimination goals for viral hepatitis
2020
NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States
2002
and 33 more

Author Peers

Author Last Decade Papers Cites
Anna S. Lok 39673 38461 3804 553 46.8k
K. Rajender Reddy 24323 27667 5180 577 36.3k
Stefan Zeuzem 32059 33445 3983 1.0k 45.8k
Zachary Goodman 32446 30336 4296 293 40.9k
Adrian M. Di Bisceglie 23266 23261 2203 380 32.6k
Ding‐Shinn Chen 28311 27144 2498 751 37.8k
Ching‐Lung Lai 27362 27083 3701 572 35.3k
Jay H. Hoofnagle 29885 29585 4086 388 42.8k
Thierry Poynard 35335 33163 4255 425 42.7k
Thomas Berg 19785 19755 1885 715 27.3k
Pei‐Jer Chen 22789 22108 2293 812 37.4k

All Works

Loading papers...

Rankless by CCL
2026